BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10313498)

  • 1. Using cost-effectiveness analysis in policy formulation in human service organizations.
    Holosko MJ; Dobrowolsky J; Feit MD
    J Health Soc Policy; 1989; 1(1):43-60. PubMed ID: 10313498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposed cost effectiveness method for use in policy formulation in human service organizations.
    Holosko MJ; Dobrowolsky J; Feit MD
    J Health Soc Policy; 1990; 1(3):55-71. PubMed ID: 10113664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
    Elbasha EH
    Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy formulation and technology assessment.
    Banta HD; Behney CJ
    Milbank Mem Fund Q Health Soc; 1981; 59(3):445-79. PubMed ID: 6792555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why don't Americans use cost-effectiveness analysis?
    Neumann PJ
    Am J Manag Care; 2004 May; 10(5):308-12. PubMed ID: 15152700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It is money that matters: decision analysis and cost-effectiveness analysis.
    Kocher MS; Henley MB
    Clin Orthop Relat Res; 2003 Aug; (413):106-16. PubMed ID: 12897601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic reviews of economic evaluations: utility or futility?
    Anderson R
    Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How should treatment costs impact on physician's decisions?
    Neymark N
    Acta Otorhinolaryngol Belg; 1999; 53(3):289-92. PubMed ID: 10635410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
    Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
    Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision support in vaccination policies.
    Piso B; Wild C
    Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic league tables: communicating cost-effectiveness results to decision-makers.
    Hutubessy RC; Baltussen RM; Evans DB; Barendregt JJ; Murray CJ
    Health Econ; 2001 Jul; 10(5):473-7. PubMed ID: 11466807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis: what is it and how will it influence neurology.
    Holloway RG
    Ann Neurol; 1996 Jun; 39(6):818-23. PubMed ID: 8651658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalised cost-effectiveness analysis: an aid to decision making in health.
    Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
    Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has the time come for cost-effectiveness analysis in US health care?
    Bryan S; Sofaer S; Siegelberg T; Gold M
    Health Econ Policy Law; 2009 Oct; 4(Pt 4):425-43. PubMed ID: 19203399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to using cost-effectiveness analysis in managed care decision making.
    Prosser LA; Koplan JP; Neumann PJ; Weinstein MC
    Am J Manag Care; 2000 Feb; 6(2):173-9. PubMed ID: 10977418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.